9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 17

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Response Rate,  Amount and severity of adverse events,  Duration of Response, Blood and tissue marker evaluation

Interventions: PF-03446962,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: April 2014

Completion Date: February 2015

Last  Posted Date: September 19, 2016

Location: Cross Cancer Institute, Edmonton, Alberta, Canada

Website Link: https://ClinicalTrials.gov/show/NCT01486368

Was this article helpful?
Dislike 0